Periconceptional Use of OnabotulinumtoxinA: Need for Comparative Safety Studies

Neurology. 2023 Jul 11;101(2):53-54. doi: 10.1212/WNL.0000000000207469. Epub 2023 May 3.

Authors

Madison Ponder¹, Mollie E Wood²

Affiliations

¹ From the Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill.
² From the Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill. mwood@unc.edu.

PMID: 37137723
DOI: 10.1212/WNL.0000000000207469

No abstract available

Publication types

Editorial
Comment

MeSH terms

Botulinum Toxins, Type A* / adverse effects
Humans
Migraine Disorders*
Neuromuscular Agents* / adverse effects
Treatment Outcome

Substances

Botulinum Toxins, Type A
Neuromuscular Agents